


01 Jai Radhe Sales (1)
02 Metrochem API Private Limited (1)
03 DKSH (1)
04 Aarti Pharmalabs (1)
05 Zeon Pharma Industries India Pvt Ltd (1)
06 LGM Pharma (1)
07 HRV Global Life Sciences (1)
08 Alkem Laboratories (1)
09 Anuh Pharma LTD (1)
10 Anwita Drugs & Chemicals Pvt Ltd (1)
11 Aspire Lifesciences Pvt Ltd (1)
12 Aurobindo Pharma Limited (1)
13 Bal Pharma (1)
14 CHEMO (1)
15 Chemeca Drugs (1)
16 Credo Life Sciences (1)
17 Egis Pharmaceuticals PLC (1)
18 Estechpharma (1)
19 GPT Pharmaceuticals (1)
20 Guangzhou Tosun Pharmaceutical (1)
21 Hana Pharm (1)
22 Hasti Aria Shimi (1)
23 Hermes Chemical (1)
24 Hetero Drugs (1)
25 Hoventa Pharma (1)
26 IIQUIAP (1)
27 JRC (1)
28 Jiangsu Nhwa Pharmaceutical (1)
29 Jin Dun Medical (1)
30 Kinsy SL (1)
31 Laurus Labs (1)
32 MSN Laboratories (1)
33 Meenaxy Pharma Pvt. Ltd (1)
34 Moehs Iberica (1)
35 Ningbo Syntame Biotech (1)
36 Nishchem International Pvt. Ltd (1)
37 Pellets Pharma Limited (1)
38 Pellsys Pharma (1)
39 Precise Group (1)
40 Qualitek pharma (1)
41 R L Fine Chem (1)
42 RA CHEM PHARMA LIMITED (1)
43 SCI PHARMTECH (1)
44 Saneca Pharmaceuticals (1)
45 Shilpa Medicare (1)
46 Shodhana Laboratories Pvt. Ltd (1)
47 Sichuan Renan Pharmaceutical (1)
48 Smilax Laboratories Limited (1)
49 Teva Pharmaceutical Industries (1)
50 Titan Laboratories Pvt Ltd. (1)
51 UQUIFA (1)
52 Viatris (1)
53 Zhejiang Hisoar Pharmaceutical (1)
54 Zhejiang Huahai Pharmaceutical (1)
55 Zhuhai Rundu Pharmaceutical (1)
56 Zim Laboratories (1)
57 Zydus Lifesciences (1)
01 DULOXETINE HCL (1)
02 Duloxetine (19)
03 Duloxetine HCl (3)
04 Duloxetine Hydrochloride (16)
05 duloxetine hydrochloride (18)
01 China (8)
02 Hungary (1)
03 India (34)
04 Iran (1)
05 Israel (1)
06 Mexico (1)
07 Slovakia (1)
08 South Korea (2)
09 Spain (4)
10 Switzerland (1)
11 Taiwan (1)
12 U.S.A (2)
Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.